147 related articles for article (PubMed ID: 3390216)
1. Inhibition of human platelet secretion and of Ca2+, calmodulin-dependent protein phosphorylation by the antiallergic agent GMCHA.
Tanaka T; Saitoh M; Ito M; Shin T; Naka M; Endo K; Hidaka H
Biochem Pharmacol; 1988 Jul; 37(13):2537-42. PubMed ID: 3390216
[TBL] [Abstract][Full Text] [Related]
2. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
[TBL] [Abstract][Full Text] [Related]
3. Ca2+-calmodulin-dependent phosphorylation and platelet secretion.
Nishikawa M; Tanaka T; Hidaka H
Nature; 1980 Oct; 287(5785):863-5. PubMed ID: 7432502
[TBL] [Abstract][Full Text] [Related]
4. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Yamakado T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
[TBL] [Abstract][Full Text] [Related]
5. P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation.
Toth-Zsamboki E; Oury C; Cornelissen H; De Vos R; Vermylen J; Hoylaerts MF
J Biol Chem; 2003 Nov; 278(47):46661-7. PubMed ID: 14500714
[TBL] [Abstract][Full Text] [Related]
6. Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine tracheal smooth muscle.
Asano M
J Pharmacol Exp Ther; 1989 Nov; 251(2):764-73. PubMed ID: 2810127
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium red inhibits the binding of calcium to calmodulin required for enzyme activation.
Sasaki T; Naka M; Nakamura F; Tanaka T
J Biol Chem; 1992 Oct; 267(30):21518-23. PubMed ID: 1383224
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
[TBL] [Abstract][Full Text] [Related]
9. Symmetric covalent linkage of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) results in novel derivatives with increased inhibitory activities against calcium/calmodulin complex.
Yokokura H; Osawa M; Inoue T; Umezawa I; Naito Y; Ikura M; Hidaka H
Drug Des Discov; 1999 Nov; 16(3):203-16. PubMed ID: 10624566
[TBL] [Abstract][Full Text] [Related]
10. Effects of calyculin A on tension and myosin phosphorylation in skinned smooth muscle of the rabbit mesenteric artery.
Suzuki A; Itoh T
Br J Pharmacol; 1993 Jul; 109(3):703-12. PubMed ID: 8395295
[TBL] [Abstract][Full Text] [Related]
11. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
Walsh MP; Sutherland C; Scott-Woo GC
Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
[TBL] [Abstract][Full Text] [Related]
12. N-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide, a novel activator of protein kinase C.
Ito M; Tanaka T; Inagaki M; Nakanishi K; Hidaka H
Biochemistry; 1986 Jul; 25(15):4179-84. PubMed ID: 3756133
[TBL] [Abstract][Full Text] [Related]
13. The Ca2+ -activated protease (calpain) modulates Ca2+/calmodulin dependent activity of smooth muscle myosin light chain kinase.
Ito M; Tanaka T; Nunoki K; Hidaka H; Suzuki K
Biochem Biophys Res Commun; 1987 Jun; 145(3):1321-8. PubMed ID: 3038096
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
[TBL] [Abstract][Full Text] [Related]
15. Calcium rather than protein kinase C is the major factor to activate phospholipase D in FMLP-stimulated rabbit peritoneal neutrophils. Possible involvement of calmodulin/myosin L chain kinase pathway.
Kanaho Y; Nishida A; Nozawa Y
J Immunol; 1992 Jul; 149(2):622-8. PubMed ID: 1624805
[TBL] [Abstract][Full Text] [Related]
16. KT5926, a potent and selective inhibitor of myosin light chain kinase.
Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H
Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions between smooth muscle myosin light chain kinase and calmodulin.
Malencik DA; Anderson SR; Bohnert JL; Shalitin Y
Biochemistry; 1982 Aug; 21(17):4031-9. PubMed ID: 6896995
[TBL] [Abstract][Full Text] [Related]
18. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
Riondino S; Gazzaniga PP; Pulcinelli FM
Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
[TBL] [Abstract][Full Text] [Related]
19. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
Inagaki M; Kawamoto S; Itoh H; Saitoh M; Hagiwara M; Takahashi J; Hidaka H
Mol Pharmacol; 1986 Jun; 29(6):577-81. PubMed ID: 2872589
[TBL] [Abstract][Full Text] [Related]
20. Ca2+-independent phosphorylation of myosin in rat caudal artery and chicken gizzard myofilaments.
Weber LP; Van Lierop JE; Walsh MP
J Physiol; 1999 May; 516 ( Pt 3)(Pt 3):805-24. PubMed ID: 10200427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
